MSEA analysis of the A.1 and B.1 branches show an enrichment of miRNAs expressed in CD14+, CD15+, CD19+, CD3+, and CD56+ immune cell types, which are known markers of neuroinflammation and have been increasingly implicated in neurodegenerative and psychiatric disorders. This evidence concerns the gene NCAM1 and psychiatric disorder.